<DOC>
	<DOCNO>NCT02972645</DOCNO>
	<brief_summary>The purpose study evaluate safety LY3305677 side effect might associate . This study also look much LY3305677 get blood stream , long take body remove . This study involve single dose LY3305677 administer subcutaneous injection ( SC ) . Participation study expect last 16 week .</brief_summary>
	<brief_title>A Study LY3305677 Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Overtly healthy determine medical history physical examination Male participant : agree use reliable method birth control donate sperm study least 3 month follow last dose investigational product Female participant : woman childbearing potential due surgical sterilization confirm medical history menopause First generation Japanese participant nonJapanese participant Have body weight 50 kilogram ( kg ) Have participate within last 3 month clinical trial involve investigational product Have know allergy glucagonlike peptide1 ( GLP1 ) analog , component formulation , history significant atopy Have abnormality 12lead electrocardiogram ( ECG ) screen and/or Day 1 Have undergone form bariatric surgery Have obvious clinical sign symptom liver disease , acute chronic hepatitis Have history acute chronic pancreatitis elevation serum lipase and/or amylase Show evidence human immunodeficiency virus ( HIV ) Hepatitis B C Have use intend use medication promote weight loss Have donate blood 500 milliliter ( mL ) within last month Currently smoke 10 cigarette per day</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>